Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer
Introduction As of 2022, breast cancer ranks as the most common malignancy occurring in women, regardless of race or ethnicity, in the United States. In 2023, it is estimated that there will be 297,790 Americans diagnosed with breast cancer, with 43,170 …